China, Korea, Taiwan, and Japan are rapidly becoming world leaders in cell and gene therapy research and innovation, fueled by significant public and private investment and streamlined regulations that are spurring breakthroughs in the field. All three countries have long been leaders... Read More
Stepping up its commitment to researching the potential of cells harvested from human embryos, China has announced plans to construct what it says will be the largest stem cell technology laboratory in Asia. China sees the development of stem cell and regenerative... Read More
This article was originally published on MedTech Intelligence. With patients and medical providers across Asia and around the world forced by the global pandemic to rely on online platforms more than ever before, the medical device industry is finding itself uniquely vulnerable... Read More
Sales of diagnostic mammography equipment in the Asia-Pacific region is expected to rise significantly over the next eight years, according to two recently published studies. The reports by Globalcan and GlobalData vary in their specific findings. But both project compound annual growth... Read More
Western investors are increasingly investing in Chinese biotechnology firms, driven by a surge in demand for cutting edge treatments for the novel coronavirus and other new therapies being developed in China. Over the past five years, Chinese firms have moved away from... Read More
This article was originally published on Medtech Intelligence Fueled by an urgent need for diagnostic testing to respond to the COVID-19 pandemic, the in-vitro diagnostics (IVD) market is experiencing explosive growth across Asia and around the globe. Already expanding for the... Read More
Aging populations and increased incidences of chronic diseases across the Asia-Pacific region are spurring rapid growth in demand for in-vitro diagnostic (IVD) testing. That presents major marketing opportunities for the diagnostics industry in China, India, Southeast Asia, Japan, South Korea, and Indonesia. ... Read More
China is increasingly emerging as a global leader in cell and gene therapy innovation, with the government granting thousands of patents in the field, and Chinese laboratories already conducting or scheduled to begin more than 1,000 clinical trials over the next two... Read More
This article was originally published on MedTech Intelligence. With the COVID-19 pandemic shuttering physician offices and walk-in clinics, patients and doctors across Asian markets have turned increasingly to telehealth solutions. The surge is creating a short-term boom—and the likelihood of a long-term... Read More
https://attendee.gotowebinar.com/recording/5890292005019691021 Read More